KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $5.4 million.

  • Bionano Genomics' Prepaid Assets rose 2258.95% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 2258.95%. This contributed to the annual value of $3.1 million for FY2024, which is 4781.53% down from last year.
  • According to the latest figures from Q3 2025, Bionano Genomics' Prepaid Assets is $5.4 million, which was up 2258.95% from $3.1 million recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' Prepaid Assets peaked at $7.3 million during Q4 2022, and registered a low of $1.7 million during Q2 2021.
  • In the last 5 years, Bionano Genomics' Prepaid Assets had a median value of $4.5 million in 2021 and averaged $4.6 million.
  • In the last 5 years, Bionano Genomics' Prepaid Assets surged by 18471.22% in 2021 and then tumbled by 4781.53% in 2024.
  • Bionano Genomics' Prepaid Assets (Quarter) stood at $4.5 million in 2021, then soared by 63.56% to $7.3 million in 2022, then dropped by 17.87% to $6.0 million in 2023, then crashed by 47.82% to $3.1 million in 2024, then soared by 71.22% to $5.4 million in 2025.
  • Its Prepaid Assets was $5.4 million in Q3 2025, compared to $3.1 million in Q2 2025 and $2.8 million in Q1 2025.